[Effect of IFN-α on hepatic cancer SMCC-7721 cell via PI3K/Akt signaling pathway and related mechanism research].
This study explored how interferon alpha (IFN-α) influenced liver cancer SMCC-7721 cell via PI3K/Akt signaling pathway. The effect of IFN-α on the viability of SMCC-7721 cell was measured by MTT assay. The effect of IFN-α on SMCC-7721 cell cycle was measured by flow cytometry. The activation of PI3K/Akt signaling pathway and downstream target genes expression level of glycogen synthase kinase 3 beta (GSK-3β), and cell cycle protein (Cyclin D1), p21, C-myc, Survivin were assayed by Western blot. MTT assay indicated IFN-α (5, 10, 15 U/L) could inhibit SMCC-7721 cell viability, and the inhibitory rate was the highest at 48 h. IFN-α made SMCC-7721 cell arrested. Western blotting assays presented IFN-α could down-regulate expression of PI3K and suppress the phosphorylation of Akt, and then inhibit phosphorylation of GSK-3β. It could also reduce the expression levels of Cyclin D1, C-myc and Survivin but increase the level of p21. These results suggested IFN-α could depress the growth and proliferation of liver cancer SMCC-7721 cell via blocking PI3K/Akt signaling pathway, and the molecular proteins Cyclin D1, p21, C-myc, Survivin were involved.